Beyond Aneuploidies: Exploring the Glycometabolic Link to Pregnancy-Associated Plasma Protein A in Pregestational Diabetes
Maternal and Children's Health · 04.03.2026 · 2 (1) · 32-40
DOI: 10.1159/000550963 ↗Kurz gefasst
Fachartikel in der Zeitschrift Maternal and Children's Health, online erschienen am 04.03.2026. Verfasst von Moira Barbieri und 9 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Pregnancy-associated plasma protein A (PAPP-A) is a glycoprotein produced by the syncytiotrophoblast and decidua, as well as vascular smooth muscle cells. While type 2 diabetes is typically associated with chronically low PAPP-A levels – contributing to vascular dysfunction – the relationship between glycometabolic control and PAPP-A in pregestational diabetes (pre-GD) remains under-explored. This study investigated the correlation between PAPP-A levels and glycated hemoglobin (HbA1c) in pregnant women with type 1 and type 2 pre-GD.
Methods
This retrospective study analyzed 96 pregnant women with pre-GD (type 1 and type 2) who underwent first-trimester combined screening. PAPP-A levels were correlated with both pregestational and first-trimester HbA1c values. In type 2 pre-GD, multivariate analysis was employed to assess the impact of HbA1c on PAPP-A levels while accounting for ethnic differences.
Results
In women with type 1 pre-GD, a significant inverse correlation was observed between PAPP-A and both pregestational (R = −0.69; p < 0.01) and first-trimester HbA1c (R = −0.49; p < 0.01). In type 2 pre-GD, multivariate analysis showed divergent results based on ethnicity: for each unit increase in HbA1c, PAPP-A decreased by 0.03 units in Caucasian women but increased by 2.7 units in South American women.
Conclusion
These findings suggest that glycometabolic compensation significantly influences PAPP-A levels. Clinical risk assessments for aneuploidy should consider HbA1c as a continuous parameter rather than treating pre-GD history as a binary variable. Incorporating specific glycometabolic data and ethnicity may improve the accuracy of first-trimester screening for women with pre-GD.
Zitieren
APA
Barbieri, M., Rossi, G., Maggi, V., Catalano, M. R., Coppa, B., Caneschi, A., Zamagni, G., Ferrazzi, E. M., Persico, N., & Cetin, I. (2026). Beyond Aneuploidies: Exploring the Glycometabolic Link to Pregnancy-Associated Plasma Protein A in Pregestational Diabetes. Maternal and Children's Health, 2(1), 32-40. https://doi.org/10.1159/000550963
Vancouver
Barbieri M, Rossi G, Maggi V, Catalano MR, Coppa B, Caneschi A, et al. Beyond Aneuploidies: Exploring the Glycometabolic Link to Pregnancy-Associated Plasma Protein A in Pregestational Diabetes. Maternal and Children's Health. 2026;2(1):32-40. doi:10.1159/000550963
BibTeX
@article{Barbieri2026,
author = {Barbieri, Moira and Rossi, Gabriele and Maggi, Valeria and Catalano, Mariana Rita and Coppa, Beatrice and Caneschi, Agnese and Zamagni, Giulia and Ferrazzi, Enrico M. and Persico, Nicola and Cetin, Irene},
title = {Beyond Aneuploidies: Exploring the Glycometabolic Link to Pregnancy-Associated Plasma Protein A in Pregestational Diabetes},
journal = {Maternal and Children's Health},
year = {2026},
volume = {2},
number = {1},
pages = {32--40},
doi = {10.1159/000550963}
}
EUVIMED